Timothy Sullivan Net Worth & Insider Trades

Timothy Sullivan - Chief Financial Officer, Apellis Pharmaceuticals, Inc

As of February 14, 2022

What is Timothy Sullivan's Net Worth?

The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Financial Officer, Timothy Sullivan, is estimated to be about $1.05M . Timothy Sullivan owns about 11,699 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Timothy Sullivan has sold an estimated value of $107.26K worth.

What is Timothy Sullivan's Past Insider Trading?

Timothy Sullivan's largest purchase order was 11,699 units , worth over $347.63K on September 3, 2019. In total, Timothy Sullivan has made about 10 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Timothy Sullivan usually trades in February, with the busiest year in 2021 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Timothy Sullivan's Salary in 2020?

As Chief Financial Officer of Apellis Pharmaceuticals, Inc, Timothy Sullivan has a total base salary of $430,269 . Timothy Sullivan received compensation valued at about $3,485,149 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $244,688 , stock awards of $518,129 , option awards of $2,279,063 , and other compensation of $13,000 .

What is Timothy Sullivan's' Mailing Address?

  • Mailing address is 800 Boylston St., Suite 3310 Prudential Tower C/o Aju Ib Investment Boston MA 02199 MA

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

What are Apellis Pharmaceuticals, Inc's Past Insider Trades?

Apellis Pharmaceuticals, Inc's most recent insider trade came on August 12, 2022 by Adam Townsend who sold 12,500 units worth $837.5K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $51.6M and bought an estimated value of $95.27M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Federico Grossi, CHIEF MEDICAL OFFICER,  Cedric Francois, Chief Executive Officer,  and Alec MacHiels, Director .

Apellis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1